These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8054851)

  • 1. The fractionation of human plasma proteins. II. The purification of human complement proteins C3, C3u, and C5 by application of affinity chromatography.
    DiScipio RG; Sweeney SP
    Protein Expr Purif; 1994 Apr; 5(2):170-7. PubMed ID: 8054851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of human complement factors C3, C5 and H.
    Lundwall A; Eggertsen G
    J Immunol Methods; 1985 Jul; 81(1):147-60. PubMed ID: 3160789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large scale isolation of functionally active components of the human complement system.
    Hammer CH; Wirtz GH; Renfer L; Gresham HD; Tack BF
    J Biol Chem; 1981 Apr; 256(8):3995-4006. PubMed ID: 6783652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid isolation and characterization of native mouse complement components C3 and C5.
    Van den Berg CW; Van Dijk H; Capel PJ
    J Immunol Methods; 1989 Aug; 122(1):73-8. PubMed ID: 2760478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Components of human complement system. Testing and isolation of C3 and C5].
    Kosiak AV; Shukun SA; Poddubkova TN; Chikh VP; Surovtsev VI
    Biokhimiia; 1990 Feb; 55(2):276-84. PubMed ID: 2340315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of the fifth component of the bovine complement system.
    Aston WP; Mhatre A; Macrae J
    Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The separation of functionally distinct forms of the third component of human complement (C3).
    Parkes C; DiScipio RG; Kerr MA; Prohaska R
    Biochem J; 1981 Mar; 193(3):963-70. PubMed ID: 6458280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fractionation of human plasma proteins. III. Purification of complement factors D and I using affinity chromatography.
    DiScipio RG
    Protein Expr Purif; 1994 Apr; 5(2):178-86. PubMed ID: 8054852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fractionation of human plasma proteins. I. Affinity purification of human complement properdin.
    DiScipio RG
    Protein Expr Purif; 1994 Apr; 5(2):164-9. PubMed ID: 8054850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of the third and fifth components of human complement: application of hydrophobic chromatography.
    Kunkel SL; Kreutzer DL; Goralnick S; Ward PA
    J Immunol Methods; 1980; 35(3-4):337-51. PubMed ID: 7400588
    [No Abstract]   [Full Text] [Related]  

  • 11. Separation of six bovine complement components and one inactivator (1, 2).
    Barta O; Nelson RA; Kuo CY
    Immunol Commun; 1976; 5(1-2):75-86. PubMed ID: 950248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and quantitation of the components of the alternative complement pathway.
    Minta JO; Gee AP
    Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
    [No Abstract]   [Full Text] [Related]  

  • 13. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.
    Schreiber RD; Pangburn MK; Medicus RG; Müller-Eberhard HJ
    Clin Immunol Immunopathol; 1980 Mar; 15(3):384-96. PubMed ID: 6899978
    [No Abstract]   [Full Text] [Related]  

  • 14. The isolation and functional purification of the first seven components of canine hemolytic complement.
    Sargent AU; Johnson SB; Richardson AK
    Immunochemistry; 1976 Oct; 13(10):823-9. PubMed ID: 1002218
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.
    Strunk RC; Eidlen DM; Mason RJ
    J Clin Invest; 1988 May; 81(5):1419-26. PubMed ID: 2966814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and purification of C3 from human plasma.
    O'Rear LD; Ross GD
    Curr Protoc Immunol; 2001 May; Chapter 13():13.3.1-13.3.16. PubMed ID: 18432716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a large scale human complement source for use in bacterial immunoassays.
    Brookes C; Kuisma E; Alexander F; Allen L; Tipton T; Ram S; Gorringe A; Taylor S
    J Immunol Methods; 2013 May; 391(1-2):39-49. PubMed ID: 23485926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing a pH-switch anti-C5 antibody as a tool for human and mouse complement C5 purification and cross-species inhibition of classical and reactive lysis.
    Zelek WM; Stott M; Walters D; Harris CL; Morgan BP
    Immunology; 2018 Nov; 155(3):396-403. PubMed ID: 29981529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the complement alternative pathway by human myoblasts in vitro: biosynthesis of C3, factor B, factor H and factor I.
    Legoedec J; Gasque P; Jeanne JF; Fontaine M
    Eur J Immunol; 1995 Dec; 25(12):3460-6. PubMed ID: 8566038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadsorbent affinity purification of the fifth component (C5) of human complement and development of a highly sensitive hemolytic assay.
    Wetsel RA; Jones MA; Kolb WP
    J Immunol Methods; 1980; 35(3-4):319-35. PubMed ID: 6995534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.